Anemia of Chronic Disease

Molecular Hematology: Third Edition

Volumn , Issue , 2010, Pages 165-168

  Ganz, Tomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anemia of chronic disease; Anemia of chronic disease second most common form of anemia; Anemia of inflammation, fatigue and exercise intolerance; Bone marrow aspiration or biopsy diagnosis of anemia of inflammation; Erythropoietin suppression by cytokines or lipopolysaccharide animal models of sepsis; Essential pathogenic feature of anemia iron restriction of hemoglobin synthesis; Hypoferremia, decrease in serum iron concentration anemia of inflammation; Inflammation and erythropoietin resistance

Indexed keywords

EID: 84885794461     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444318531.ch13     Document Type: Chapter

References (58)

1. Weiss G , Goodnough LT. ( 2005) Anemia of chronic disease. New England Journal of Medicine , 352 , 1011-1023.
2. Hastka J , Lasserre JJ , Schwarzbeck A , Strauch M , Hehlmann R. ( 1993) Zinc protoporphyrin in anemia of chronic disorders. Blood , 81 , 1200-1204.
3. Wians FH Jr , Urban JE , Keffer JH , Kroft SH. ( 2001) Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration. American Journal of Clinical Pathology , 115 , 112-118.
4. Kawabata H , Tomosugi N , Kanda J , Tanaka Y , Yoshizaki K , Uchiyama T. ( 2007 ) Anti -interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman ' s disease. Haematologica , 92 , 857-858.
5. Kemna E , Pickkers P , Nemeth E , van der Hoeven H , Swinkels D. ( 2005) Time -course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood , 106 , 1864-1866.
6. Nemeth E , Rivera S , Gabayan V et al. ( 2004) IL -6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. Journal of Clinical Investigation , 113 , 1271-1276.
7. Rivera S , Nemeth E , Gabayan V , Lopez MA , Farshidi D , Ganz T. ( 2005) Synthetic hepcidin causes rapid dose -dependent hypoferremia and is concentrated in ferroportin -containing organs. Blood , 106 , 2196-2199.
8. Nicolas G , Bennoun M , Porteu A et al. ( 2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proceedings of the National Academy of Sciences of the United States of America , 99 , 4596-4601.
9. Roy CN , Mak HH , Akpan I , Losyev G , Zurakowski D , Andrews NC. ( 2007 ) Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood , 109 , 4038-4044.
10. Weinstein DA , Roy CN , Fleming MD , Loda MF , Wolfsdorf JI , Andrews NC. ( 2002 ) Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood , 100 , 3776-3781.
11. Cash JM , Sears DA. ( 1989 ) The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients. American Journal of Medicine , 87 , 638-644.
12. Cazzola M , Ponchio L , de Benedetti F et al. ( 1996 ) Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic -onset juvenile chronic arthritis. Blood , 87 , 4824-4830.
13. Corwin HL , Krantz SB. ( 2000) Anemia of the critically ill: " acute " anemia of chronic disease. Critical Care Medicine , 28 , 3098-3099.
14. Corwin HL , Krantz SB. ( 2000) Anemia of the critically ill: " acute " anemia of chronic disease. Critical Care Medicine , 28 , 3098-3099.
15. Rouault TA , Tong WH. ( 2008) Iron-sulfur cluster biogenesis and human disease. Trends in Genetics , 24 , 398-407.
16. Pearson HA , Lobel GS , Kocoshis SA et al. ( 1979) A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. Journal of Pediatrics , 6 , 976-984.
17. Rotig A , Bourgeron T , Chretien D , Rustin P , Munnich A. ( 1995) Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Human Molecular Genetics , 4 , 1327-1330.
18. Rotig A , Bourgeron T , Chretien D , Rustin P , Munnich A. ( 1995) Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Human Molecular Genetics , 4 , 1327-1330.
19. Young NS. ( 2002) Acquired aplastic anemia. Annals of Internal Medicine , 136 , 534-546.
20. Young NS , Barrett AJ. ( 1995 ) The treatment of severe acquired aplastic anemia. B lood , 85 , 3367-3377.
21. Young NS , Maciejewski J. ( 1997) The pathophysiology of acquired aplastic anemia. New England Journal of Medicine , 336 , 1365-1372.
22. Young NS , Scheinberg P , Calado RT. ( 2008) Aplastic anemia. Current Opinion in Hematology , 15 , 162-168.
23. Almeida AM , Murakami Y , Layton DM et al. ( 2006) Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency. Nature Medicine , 12 , 846-851.
24. Araten DJ , Nafa K , Pakdeesuwan K , Luzzatto L. ( 1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proceedings of the National Academy of Sciences of the United States of America , 96 , 5209-5214.
25. Hillmen P , Young NS , Schubert J et al. ( 2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. New England Journal of Medicine , 355 , 1233-1243.
26. Luzzatto L , Bessler M. ( 1996) The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. Seminars in Hematology , 3 , 101-110.
27. Takeda J , Miyata T , Kawagoe K et al. ( 1993 ) Deficiency of the GPI anchor caused by a somatic mutation of the PIG -A gene in paroxysmal nocturnal hemoglobinuria. Cell , 73 , 703-711.
28. Alter B , Young NS. ( 1998) The bone marrow failure syndromes. In: Nathan DG , Orkin SH (eds). Nathan and Oski ' s Hematology of Infancy and Childhood , 5th edn. Philadelphia: WB Saunders, pp. 237-335.
29. Andreassen PR , D'Andrea AD , Taniguchi T. ( 2004) ATR couples FANCD2 monoubiquitination to the DNA -damage response. Genes and Development , 18 , 1958-1963.
30. Cohn MA , D'Andrea AD. ( 2008) Chromatin recruitment of DNA repair proteins: lessons from the Fanconi anemia and double -strand break repair pathways. Molecular Cell , 32 , 306-312.
31. Garcia-Higuera I , Taniguchi T , Ganesan S et al. ( 2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Molecular Cell , 7 , 249-262.
32. Howlett NG , Taniguchi T , Olson S et al. ( 2002 ) Biallelic inactivation of BRCA2 in Fanconi anemia. Science , 297 , 606-609.
33. Joenje H , Patel KJ. ( 2001) The emerging genetic and molecular basis of Fanconi anaemia. Nature Reviews. Genetics , 2 , 446-459.
34. Levitus M , Waisfisz Q , Godthelp BC et al. ( 2005 ) The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nature Genetics , 37 , 934-935.
35. Litman R , Peng M , Jin Z et al. ( 2005 ) BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell , 8 , 255-265.
36. Meetei AR , Medhurst AL , Ling C et al. ( 2005) A human ortholog of archaeal DNA repair protein HEF is defective in Fanconi anemia complementation group M. Nature Genetics , 37 , 958-963.
37. Mosedale G , Niedzwiedz W , Alpi A et al. ( 2005 ) The vertebrate Hef ortholog is a component of the Fanconi anemia tumor -suppressor pathway. Nature Structural and Molecular Biology , 12 , 763-771.
38. Niedzwiedz W , Mosedale G , Johnson M , Ong CY , Pace P , Patel KJ. ( 2004 ) The Fanconi anaemia gene FANCC promotes homologous recombination and error -prone DNA repair. Molecular Cell , 15 , 607-620.
39. Pichierri P , Rosselli F. ( 2004 ) The DNA crosslink -induced S -phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO Journal , 23 , 1178-1187.
40. Strathdee CA , Gavish H , Shannon WR , Buchwald M. ( 1992) Cloning of cDNAs for Fanconi ' s anaemia by functional complementation. Nature , 356 , 763-767.
41. Venkitaraman AR. ( 2004 ) Tracing the network connecting BRCA and Fanconi anaemia proteins. Nature Reviews. Cancer , 4 , 266-276.
42. Wang W. ( 2007) Emergence of a DNA -damage response network consisting of Fanconi anaemia and BRCA proteins. Nature Reviews. Genetics , 8 , 735-748.
43. Wang X , Andreassen PR , D ' Andrea AD. ( 2004 ) Functional interaction of monoubiquitinated FANCD2 and BRCA2 / FANCD1 in chromatin. Molecular and Cellular Biology , 24 , 5850-5862.
44. Xia B , Dorsman JC , Ameziane N et al. ( 2007 ) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nature Genetics , 39 , 159-161.
45. Yamamoto K , Ishiai M , Matsushita N et al. ( 2003) Fanconi anemia FANCG protein in mitigating radiation -and enzyme -induced DNA double -strand breaks by homologous recombination in vertebrate cells. Molecular and Cellular Biology , 23 , 5421-5430.
46. Autexier C , Lue NF. ( 2006) The structure and function of telomerase reverse transcriptase. Annual Review of Biochemistry , 75 , 493-517.
47. Heiss NS , Knight SW , Vulliamy JT et al. ( 1998) X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nature Genetics , 19 , 32-38.
48. Kirwan M , Dokal I. ( 2008) Dyskeratosis congenita: a genetic disorder of many faces. Clinical Genetics , 73 , 103-112.
49. Mitchell JR , Wood E , Collins K. ( 1999 ) A telomerase component is defective in the human disease dyskeratosis congenita. Nature , 402 , 551-555.
50. Vulliamy T , Marrone A , Goldman F et al. ( 2001 ) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. N ature , 413 , 432-435.
51. Vulliamy T , Marrone A , Goldman F et al. ( 2001 ) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. N ature , 413 , 432-435.
52. Draptchinskaia N , Gustavsson P , Andersson B et al. ( 1999) The gene encoding ribosomal protein S19 is mutated in Diamond -Blackfan anaemia. Nature Genetics , 21 , 169-175.
53. Farrar E , Nater M , Caywood E et al. ( 2008) Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond -Blackfan anemia. Blood , 112 , 1582-1592.
54. Vlachos A , Ball S , Dahl N et al. ( 2008 ) Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. British Journal of Haematology , 142 , 859-876.
55. Beutler E. ( 1994) Glucose-6-phosphate dehydrogenase deficiency. New England Journal of Medicine , 324 , 169-174.
56. Hirono A , Kanno H , Miwa S , Beutler E ( 2001) Pyruvate deficiency and other enzymopathies of the erythrocyte. In: Scriver CR , Beaudet AL , Sly WS , Valle D (eds). The Metabolic and Molecular Basis of Inherited Disease , 8th edn. New York : McGraw -Hill , pp. 4637-4664.
57. Luzzatto L , Mehta A , Vulliamy T. ( 2001) Glucose-6-phosphate dehydrogenase deficiency. In: Scriver CR , Beaudet AL , Sly WS , Valle D (eds). The Metabolic and Molecular Basis of Inherited Disease , 8th edn. New York : McGraw -Hill , pp. 4517-4553.
58. Mentzer WC. ( 1998) Pyruvate kinase deficiency and disorders of glycolysis. In: Nathan DG , Orkin SH (eds). Nathan and Oski ' s Hematology of Infancy and Childhood , 5th edn. Philadelphia: WB Saunders, pp. 665-703.